Hap Trading, LLC Alnylam Pharmaceuticals, Inc. Call Options Transaction History

Hap Trading, LLC

8 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 12, 2024	SELL	$233.81 - $287.01 $1.24 Million - $1.52 Million	-5,300 Reduced 53.54%	4,600 $586 Million
Q2 2024 Aug 14, 2024	SELL	$143.31 - $247.0 $6.66 Million - $11.5 Million	-46,500 Reduced 82.45%	9,900 $556 Million
Q1 2024 May 13, 2024	BUY	$146.51 - $198.2 $8.26 Million - $11.2 Million	56,400 New	56,400 $394 Million
Q3 2023 Nov 09, 2023	BUY	$170.77 - $211.65 $4.39 Million - $5.44 Million	25,700 New	25,700 $4.55 Million
Q2 2018 Aug 13, 2018	SELL	$88.31 - $107.8 $3.04 Million - $3.71 Million	-34,400 Closed	0 $0
Q1 2018 May 11, 2018	BUY	$115.92 - $148.54 $927,360 - $1.19 Million	8,000 Added 30.3%	34,400 $21,000
Q4 2017 Feb 09, 2018	SELL	$114.49 - $139.98 $17.5 Million - $21.4 Million	-152,700 Reduced 85.26%	26,400 $30,000
Q3 2017 Nov 08, 2017	BUY	$72.53 - $118.27 $13 Million - $21.2 Million	179,100	179,100 $3.82 Million

643

109M

1.28M

1.21M

Ticker ALNY
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 123,028,000
Market Cap $28.7B
Description
Alnylam Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and commercializing novel therapeutics based on ribonucleic acid interference. The company's pipeline of investigational RNAi therapeutics focuses on genetic medicines, cardio-metabolic diseases, hepatic infectious diseases, and central nervous system...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.